Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -26.1%
DAWN
Day One Biopharmaceuticals, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 15.7 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -33.2%
- 5yr Share-Count CAGR 10.8%
Growth Quality
Weight: 35%
F
20
- Revenue-Growth Years (5) 1/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -63.5%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
C
55
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 18.80
Stability
Weight: 5%
B-
64
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.0 of 3 gurus held; 3 full exits.
- Holders
- 0 -3
- Avg Δ position
- —
- New buys
- 0
- Full exits
- 3